A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

PACS Group, Inc. PACS

Weak broader-coverage candidate · PACS Group, Inc. operates as a holding company, primarily focused on delivering post-acute healthcare services. This encompasses operating various facilities, providing skilled pro

On FrontierLab's discovery record since 2026-07-02 (13 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Weak" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-09-19), not the curated Frontier signal.

Key quality signals

Revenue growth (YoY)	15.2%
Gross margin	19.7%
Gross profits / assets	0.19
Rule of 40	22.6
Net margin	7.4%
Cash runway (months)	—
PEG	0.2
Price / sales	1.2

Quality checklist

~ Revenue growth — 15.2% (pass ≥ 20%)
✗ Gross profits / assets — 0.19 (pass ≥ 0.33)
✗ Gross margin — 19.7% (pass ≥ 60%)
✓ Cash generation
✓ Share dilution — -2.1%

Fundamentals — snapshot as of 2026-09-19

Stage	Established
Share issuance (YoY)	-2.1% · buying back shares
Moat	—
TAM	—
P/E (trailing)	25.2
EPS (trailing)	$1.67
Burn multiple	—
Gross-margin trend (pts)	2.7
Cash / assets	0.03
Net debt / EBITDA	6.4
Statements as of	Q2 FY2026 · filed 2026-08-04

Momentum context — a snapshot from 2026-09-19, not current

Price at surface	$42.12 (as of 2026-09-19)
52-week range	$10.31 – $49.49
% off 52-wk high	-14.9%
RSI (14)	41
Relative volume	1.7×

Risk flags

Thin gross margin — keeps little of each sales dollar (judge it against its industry).

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-09-19 (end-of-day). How grades are computed →